Cirrus Logic vs Silicon Laboratories
CRUS and SLAB side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRUS and SLAB compare
Silicon Laboratories is the larger company, worth 1.2 times as much as Cirrus Logic ($7.4B against $6.0B).
Silicon Laboratories grew revenue faster over the last twelve months (21.3% versus 5.1% for Cirrus Logic).
Cirrus Logic keeps more of each dollar of sales as profit, with a net margin of 20.2% compared with −2.3% at Silicon Laboratories.
Cirrus Logic scores higher on the StockData Score (20 against 7 for Silicon Laboratories), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRUS | SLAB |
|---|---|---|
| Size and price | ||
| Market cap | $6.0B | $7.4B |
| Share price | $120.19 | $221.43 |
| Change, 1 year | −1.0% | 74.4% |
| Change, 5 years | 47.2% | 7.9% |
| Beta (5Y) | 1.12 | 1.36 |
| Employees | 1,668 | 1,930 |
| StockData Score | ||
| Total score | 20 (better) | 7 |
| Valuation score | 6 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 6 (better) | 0 |
| Health score | 6 (better) | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 15.2× | – |
| P/S | 2.9× (better) | 8.2× |
| P/B | 2.7× (better) | 6.6× |
| EV/EBITDA | 10.3× | – |
| P/FCF | 11.4× (better) | 1041× |
| PEG | 0.42 | – |
| FCF yield | 8.7% (better) | 0.10% |
| Fair value | $174.32 | $128.32 |
| Margin of safety | 31.1% (better) | −72.6% |
| Growth | ||
| Revenue growth (TTM) | 5.1% | 21.3% (better) |
| Revenue growth, 5Y average | 7.8% | 9.0% (better) |
| Net income growth (TTM) | 9.0% | – |
| EPS growth (TTM) | 12.6% | – |
| EPS growth, 5Y average | 16.7% | – |
| Profitability | ||
| Gross margin | 53.1% | 61.3% (better) |
| Operating margin | 22.5% (better) | −2.6% |
| Net margin | 20.2% (better) | −2.3% |
| FCF margin | 25.7% (better) | 0.79% |
| Return on equity | 19.5% (better) | −1.9% |
| Return on invested capital | 26.1% (better) | −2.2% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | 452× (better) | −25.0× |
| Current ratio | 6.41 (better) | 4.60 |
| Altman Z-score | 11.16 | 23.12 (better) |
| Piotroski F-score | 9 (better) | 6 |
| Dividends and buybacks | ||
| Buyback yield | 5.0% | – |
| Shareholder yield | 5.0% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 106% | 93.2% |
| Held by insiders | 0.64% | 2.2% |
| Insider net buying, 12 months | −$12.4M | −$4.2M (better) |
| Short interest, % of float | 7.6% | 5.2% |
Go deeper
- CRUS stock overview
- CRUS income statement
- CRUS valuation and score
- SLAB stock overview
- SLAB income statement
- SLAB valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.